Guy W. Amsden

1.9k total citations
68 papers, 1.4k citations indexed

About

Guy W. Amsden is a scholar working on Epidemiology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Guy W. Amsden has authored 68 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 34 papers in Pharmacology and 13 papers in Infectious Diseases. Recurrent topics in Guy W. Amsden's work include Antibiotics Pharmacokinetics and Efficacy (31 papers), Pneumonia and Respiratory Infections (26 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Guy W. Amsden is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (31 papers), Pneumonia and Respiratory Infections (26 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Guy W. Amsden collaborates with scholars based in United States, Argentina and United Kingdom. Guy W. Amsden's co-authors include Anne N. Nafziger, Jennifer Victory, Manjunath P. Pai, Kevin W. Garey, George Foulds, Charles A. Peloquin, Charles H. Ballow, Greg C. G. Wei, Alan Forrest and Charles Knirsch and has published in prestigious journals such as CHEST Journal, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Guy W. Amsden

67 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guy W. Amsden United States 22 577 383 288 284 169 68 1.4k
Olivier Petitjean France 22 450 0.8× 667 1.7× 213 0.7× 246 0.9× 90 0.5× 89 1.6k
P Periti Italy 21 505 0.9× 450 1.2× 231 0.8× 216 0.8× 164 1.0× 107 1.9k
F Vauzelle-Kervroëdan France 17 399 0.7× 258 0.7× 151 0.5× 103 0.4× 109 0.6× 38 1.3k
Heino Staß Germany 21 424 0.7× 614 1.6× 256 0.9× 171 0.6× 55 0.3× 54 1.2k
George Foulds United States 25 940 1.6× 791 2.1× 187 0.6× 599 2.1× 117 0.7× 46 2.1k
Paul M. Beringer United States 22 362 0.6× 500 1.3× 348 1.2× 333 1.2× 44 0.3× 64 1.4k
Daniel P. Healy United States 23 451 0.8× 873 2.3× 98 0.3× 361 1.3× 82 0.5× 62 1.7k
Richard D. Leff United States 25 722 1.3× 326 0.9× 171 0.6× 828 2.9× 102 0.6× 86 2.0k
C Regamey Switzerland 19 401 0.7× 718 1.9× 111 0.4× 276 1.0× 78 0.5× 56 1.3k
Lee B. Barradell 18 257 0.4× 323 0.8× 119 0.4× 181 0.6× 94 0.6× 24 1.3k

Countries citing papers authored by Guy W. Amsden

Since Specialization
Citations

This map shows the geographic impact of Guy W. Amsden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy W. Amsden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy W. Amsden more than expected).

Fields of papers citing papers by Guy W. Amsden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy W. Amsden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy W. Amsden. The network helps show where Guy W. Amsden may publish in the future.

Co-authorship network of co-authors of Guy W. Amsden

This figure shows the co-authorship network connecting the top 25 collaborators of Guy W. Amsden. A scholar is included among the top collaborators of Guy W. Amsden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy W. Amsden. Guy W. Amsden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zervos, Marcus, et al.. (2006). Efficacy and safety of 3-day azithromycin versus 5-day moxifloxacin for the treatment of acute bacterial exacerbations of chronic bronchitis. International Journal of Antimicrobial Agents. 29(1). 56–61. 19 indexed citations
2.
Edmonds, Lee C., Michael Bauer, Peter J. Jederlinic, et al.. (2005). The Disease-Modifying Effects of Twice-Weekly Oral Azithromycin in Patients with Bronchiectasis. PubMed. 4(2). 117–122. 100 indexed citations
3.
Amsden, Guy W.. (2005). Treatment of Legionnaires??? Disease. Drugs. 65(5). 605–614. 26 indexed citations
4.
5.
6.
Amsden, Guy W., et al.. (2004). Characterization of the Penetration of Garenoxacin into the Breast Milk of Lactating Women. The Journal of Clinical Pharmacology. 44(2). 188–192. 3 indexed citations
7.
Amsden, Guy W., et al.. (2003). Lack of Bioequivalence of Levofloxacin When Coadministered with a Mineral‐Fortified Breakfast of Juice and Cereal. The Journal of Clinical Pharmacology. 43(9). 990–995. 11 indexed citations
8.
9.
Hauben, Manfred & Guy W. Amsden. (2002). The Association of Erythromycin and Infantile Hypertrophic Pyloric Stenosis. Drug Safety. 25(13). 929–942. 23 indexed citations
10.
Amsden, Guy W., et al.. (2001). Interpretation of Antibacterial Susceptibility Reports. Drugs. 61(2). 163–166. 4 indexed citations
11.
Pai, Manjunath P., James Bordley, & Guy W. Amsden. (2001). Plasma Pharmacokinetics and Tissue Penetration of Alatrofloxacin in Morbidly Obese Individuals. Clinical Drug Investigation. 21(3). 219–224. 2 indexed citations
12.
Amsden, Guy W., George Foulds, & Kamlesh M. Thakker. (2000). Pharmacokinetic Study of Azithromycin with Fluconazole and Cotrimoxazole (Trimethoprim-Sulfamethoxazole) in Healthy Volunteers. Clinical Drug Investigation. 20(2). 135–142. 1 indexed citations
13.
Amsden, Guy W., et al.. (2000). Azithromycin: indications for the future?. Expert Opinion on Pharmacotherapy. 1(3). 489–505. 18 indexed citations
14.
Garey, Kevin W. & Guy W. Amsden. (1999). Trovafloxacin: An Overview. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(1). 21–34. 29 indexed citations
15.
Amsden, Guy W., et al.. (1999). A Randomized, Crossover Design Study of the Pharmacology of Extended-Spectrum Fluoroquinolones for Pneumococcal Infections. CHEST Journal. 116(1). 115–119. 14 indexed citations
16.
McConnell, Scott A. & Guy W. Amsden. (1999). Review and Comparison of Advanced‐Generation Macrolides Clarithromycin and Dirithromycin. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(4). 404–415. 14 indexed citations
17.
Ballow, Charles H., et al.. (1998). Pharmacokinetics of Oral Azithromycin in Serum, Urine, Polymorphonuclear Leucocytes and Inflammatory vs Non-Inflammatory Skin Blisters in Healthy Volunteers. Clinical Drug Investigation. 15(2). 159–167. 38 indexed citations
18.
Garey, Kevin W., Guy W. Amsden, & Celeste A. Johns. (1997). Possible Interaction Between Imipramine and Butalbital. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(5). 1041–1042. 3 indexed citations
19.
Amsden, Guy W. & Charles H. Ballow. (1996). Prospective Validation of an Optimal Sparse Plasma‐Sampling Strategy for Estimating Ciprofloxacin Pharmacokinetics. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(5). 937–941. 3 indexed citations
20.
Amsden, Guy W., et al.. (1996). Orthostatic Hypotension Induced by Sertraline Withdrawal. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 16(4). 684–686. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olivier Petitjean Breakdown of academic impact, for papers by P Periti Breakdown of academic impact, for papers by F Vauzelle-Kervroëdan Breakdown of academic impact, for papers by Heino Staß Breakdown of academic impact, for papers by George Foulds Breakdown of academic impact, for papers by Paul M. Beringer Breakdown of academic impact, for papers by Daniel P. Healy Breakdown of academic impact, for papers by Richard D. Leff Breakdown of academic impact, for papers by C Regamey Breakdown of academic impact, for papers by Lee B. Barradell
Rankless by CCL
2026